1. Home
  2. GLPG vs SNDA Comparison

GLPG vs SNDA Comparison

Compare GLPG & SNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$29.39

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Sonida Senior Living Inc.

SNDA

Sonida Senior Living Inc.

HOLD

Current Price

$34.51

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLPG
SNDA
Founded
1999
1990
Country
Belgium
United States
Employees
704
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
GLPG
SNDA
Price
$29.39
$34.51
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$36.50
$35.25
AVG Volume (30 Days)
198.6K
566.9K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$381,141,000.00
Revenue This Year
N/A
$68.24
Revenue Next Year
N/A
$11.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.24
52 Week Low
$24.59
$20.30
52 Week High
$37.78
$37.57

Technical Indicators

Market Signals
Indicator
GLPG
SNDA
Relative Strength Index (RSI) 42.14 56.42
Support Level $28.78 $30.78
Resistance Level $34.04 $37.57
Average True Range (ATR) 0.64 1.27
MACD 0.15 0.37
Stochastic Oscillator 52.52 69.19

Price Performance

Historical Comparison
GLPG
SNDA

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

About SNDA Sonida Senior Living Inc.

Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic services offered by the company at its senior housing communities comprise meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.

Share on Social Networks: